The new T cells could help clinicians avoid the relapses that can occur in patients whose lymphoma cells lose CD19 - a prominent roadblock in standard CAR T cell therapy for B cell malignancies.
from Medindia Health News https://ift.tt/2lB62Mw
No comments:
Post a Comment